Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
This is a first-in-human phase I/II randomized, double-blind, placebo (vehicle)-controlled,
multicenter study to assess the Safety and Efficacy of AVX-012 Ophthalmic Solution in
subjects with Mild-to-Moderate Dry Eye Syndrome.
The study consists of two parts (part A and part B):